Johnson Pharmacare Limited
BSE: JOHNPHARMA · Diversified Commercial Services · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 95 companies in Diversified Commercial Services (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹21 cr (FY26): borrowings are higher by ₹21 cr.
- Operating profit covered interest -42.0x in the last 12 months.
- Net loss in 5 of the last 6 quarters.
- No dividend in the last 5 financial years.
- Price ₹0.40 on 2026-10-26: -42.9% from the 52-week high, +5.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -0 | -0 | 0 | -0 | -57 | -0 |
| OPM % | – | – | – | – | – | – |
| Other income | -0 | 0 | 0 | 0 | 2 | 0 |
| Net profit | -1 | -0 | 0 | -0 | -56 | -1 |
| EPS (₹) | 0.01 | 0.00 | 0.00 | 0.00 | 1.01 | 0.02 |
| Revenue YoY | – | – | ||||
| Profit YoY | – | – |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 3 | 3 | – | 0 | 0 | 0 |
| EBITDA | 0 | 0 | -0 | -0 | -57 | -57 |
| Net profit | 0 | -1 | -0 | -1 | -56 | -57 |
| EPS (₹) | 0.02 | -0.02 | – | 0.01 | 1.01 | 1.03 |
| Revenue growth | -22.4% | – | – | – | – | |
| Profit growth | -1,390.0% | – | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -37.2% (2y) | -39.1% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 56 | 0 |
| Borrowings | 1 | 21 |
| Cash & equivalents | 0 | 0 |
| Total assets | 58 | 22 |
| Fixed assets | 0 | 0 |
| Capital work in progress | 0 | – |
| Investments | 42 | 20 |
| Receivables | 0 | 2 |
| Inventory | 0 | 0 |
| Payables | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -2 | -58 |
| Cash from investing | 3 | 37 |
| Cash from financing | -1 | 21 |
| Capex | 0 | 0 |
| Free cash flow | -2 | -58 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | -1.0% | -12,806.5% |
| ROCE % | -1.0% | -254.0% |
Peers in Diversified Commercial Services
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| IGIL | ₹16,651 cr | 25.0x | 9.5x | 44.5% | 51.7% | 61.5% | – | 1.93% |
| WEWORK | ₹8,640 cr | 99.1x | 29.0x | 28.3% | 111.2% | 64.6% | – | – |
| IBULLSLTD | ₹6,919 cr | – | 1.1x | -0.4% | – | – | +918.1% | – |
| NESCO | ₹6,699 cr | 16.1x | 2.2x | 14.8% | 18.3% | 50.8% | +19.5% | 0.69% |
| NIRLON | ₹5,679 cr | 15.9x | 12.1x | 86.5% | 29.8% | 77.5% | +5.3% | 4.12% |
| RENTOMOJO | ₹5,292 cr | – | – | – | – | – | – | – |
| LEAPIND | ₹5,209 cr | – | – | – | – | – | – | – |
| SMARTWORKS | ₹5,085 cr | 182.4x | 9.6x | 5.2% | 56.6% | 64.2% | – | – |
| QUESS | ₹4,827 cr | 19.1x | 4.1x | 22.4% | 27.2% | 2.0% | -3.7% | – |
| JOHNPHARMA | ₹22 cr | 0.4x | 50.5x | -200.6% | -254.0% | – | – | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Services |
| Industry | Diversified Commercial Services |
| Sub-industry | Diversified Commercial Services |
| Symbol | JOHNPHARMA |
| BSE code | 532154 |
| ISIN | INE560F01022 |
| Face value | ₹1.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.